Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators

Xiao-li Lia Department of Endocrinology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China;b Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information

Yan-fei Jic Department of Obstetrics and Gynecology, Second Hospital of Shanxi Medical University, Taiyuan, ChinaView further author information

Yu Fenga Department of Endocrinology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China;b Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaView further author information

Shi-wei Liua Department of Endocrinology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China;b Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCorrespondence[email protected]
View further author information

Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators

Table 1. Symptoms And physical signs in the OP, NP, ON, and NN groups.

Table 2. Changes in sex hormone-associated indicators in the OP, NP, ON, and NN groups $(\bar{x} \pm s)$ .

Table 3. Changes in metabolism-associated indicators in the OP, NP, ON, and NN groups $(\bar{x} \pm s)$ .

Table 4. Changes in ER-associated indicators in the OP, NP, ON, and NN groups $(\bar{x} \pm s)$ .

Table 5. Correlation between FAI (%) and metabolism-associated indicators.

Table 6. Correlation between SHBG and metabolism-associated indicators.

Table 7. Correlation between RI with sex hormone-associated and metabolism-associated indicators.

Table 8. Correlation between uterine artery S/D with sex hormone-associated and metabolism-associated indicators.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators

Figures & data

Table 1. Symptoms And physical signs in the OP, NP, ON, and NN groups.

Table 2. Changes in sex hormone-associated indicators in the OP, NP, ON, and NN groups (x¯±s).

Table 3. Changes in metabolism-associated indicators in the OP, NP, ON, and NN groups (x¯±s).

Table 4. Changes in ER-associated indicators in the OP, NP, ON, and NN groups (x¯±s).

Table 5. Correlation between FAI (%) and metabolism-associated indicators.

Table 6. Correlation between SHBG and metabolism-associated indicators.

Table 7. Correlation between RI with sex hormone-associated and metabolism-associated indicators.

Table 8. Correlation between uterine artery S/D with sex hormone-associated and metabolism-associated indicators.

Data availability statement

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Table 2. Changes in sex hormone-associated indicators in the OP, NP, ON, and NN groups $(\bar{x} \pm s)$ .

Table 3. Changes in metabolism-associated indicators in the OP, NP, ON, and NN groups $(\bar{x} \pm s)$ .

Table 4. Changes in ER-associated indicators in the OP, NP, ON, and NN groups $(\bar{x} \pm s)$ .